Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DPH1 antisense RNA 1 is a long non-coding RNA transcribed from the antisense strand of the DPH1 gene locus. It belongs to the lncRNA group and functions as an antisense RNA, meaning it can regulate gene expression through a variety of mechanisms including transcriptional interference, chromatin modification, and stabilization or degradation of target mRNAs[2][3][7]. Antisense RNAs often exhibit regulatory effects in cis by affecting the allele from which they are transcribed, or in trans by modulating distant alleles, and can influence processes such as gene silencing and epigenetic modifications[2][3]. While some antisense lncRNAs are implicated in human diseases such as cancer or neurological conditions, the specific disease roles and molecular partners for DPH1-AS1 have not been well characterized, aside from an association noted with opioid abuse[7]. DPH1-AS1 is not considered a conventional therapeutic target (receptor, enzyme, etc.), nor is it currently linked to known drugs, mechanisms of drug action, biomarkers, or notable safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DPH1 antisense RNA 1 (DPH1-AS1).